Drug regulators have introduced stricter rules to eliminate duplicate and deceptively similar medicine brand names. The new First-to-Register policy and mandatory Sugam portal verification aim to prevent medication errors, improve patient safety and ensure unique brand names across the pharmaceutical industry.
The CDSCO has clarified that cosmetic products cannot be used as injections, potentially impacting aesthetic and wellness clinics offering glow shots and skin boosters. The directive empowers regulators to inspect facilities and urges the public to report violations.
Paediatricians in Hyderabad have urged CDSCO to mandate single-strength formulations for commonly used drugs like paracetamol, warning that multiple strengths confuse parents and lead to accidental overdosing in children. They emphasised adopting uniform strengths to prevent avoidable ICU admissions.
The company plans to introduce Beyfortus, which contains the monoclonal antibody nirsevimab, in a prefilled injection used for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease (LRTD) in newborns and infants
Moderna has also informed that the US Government has agreed to donate a certain number of doses of the Moderna COVID-19 vaccine through COVAX to the Government of India
